Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Tin Compounds”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 343 records · Page 19Linked to original sources

A new technology for direct restorative alloys.

OBJECTIVES: The purpose of this study was to develop a new technology for preparing mercury-free metallic dental restorative materials. METHODS: The novel approach relies on the cold welding of surface treated silver particles. At ambient temperature, intermetallic compound formation takes place spontaneously at the silver-tin interface. The ability of a loose powder to consolidate at ambient temperature under moderate pressure and within a short time duration was investigated for various mixtures of elemental silver, tin, and pre-alloyed silver-coated powders. Surface treatment aimed at removing silver surface oxide layers is done with a dilute acid. The compressive and the transverse rupture strengths of several of the consolidated powder mixtures were determined. RESULTS: Cold-welding of surface-treated powder particles takes place across the silver-silver interface and is promoted by exposure to a mild acid. Powder mixtures containing approximately 50% silver powder, 40% silver-coated silver-tin intermetallic compound particles, and a small silver-tin fraction deposited from an aqueous solution display very good condensability, depending on the amount of silver-silver interface area available. The attained rupture strength values (200 Mpa) were higher than those of amalgams; the compressive strengths (120 MPa) and hardness values (100 KHN), however, were lower than those found for amalgams. SIGNIFICANCE: Mercury-free silver-tin powder mixtures can be processed for use as metallic composite dental restorative materials.

Analysis of Variance↗

Preparation and properties of 99Tcm-exametazime using stannous ion augmentation of fractionated cold kits.

Fractionation of 99Tcm-exametazime enables several patients doses to be prepared from one vial. To overcome the disadvantages of storage at -70 degrees C, storage at higher temperatures was investigated with replacement of stannous ions before use. Kits were fractionated using a nitrogen-purged 0.9% w/v sodium chloride injection, sub-dispensed into five nitrogen-filled vials in an aseptic environment and stored at -20 degrees C. Under these conditions, exametazime vials failed quality control in approximately 1 week. However, the addition of stannous pyrophosphate solution (10 micrograms Sn(II) in 0.1 ml, prepared by aseptic dilution of a red blood cell labelling kit) immediately before 99Tcm-pertechnetate produced 90.1 +/- 1.6% (n = 8) lipophilic complex with a normal rate of decomposition. Biodistribution studies of this product in mice compared with the full kit showed identical brain and other organ uptakes. This product was used for cerebral imaging in patients with 90.5 +/- 3.3% lipophilic complex (n = 647) at approximately 3 min and produced excellent clinical results. It is concluded that stannous ion augmentation ('reboot') using approved Sn(II)-pyrophosphate kits is a viable option for institutions with facilities for aseptic preparation of fractionated exametazime kits, enabling substantial cost savings. Other advantages include removal of restrictions on generator eluate and 'rejuvenation' of expired kits.

Animals↗

99Tcm-(tin) colloid scans in the evaluation of renal transplant rejection.

Technetium-99m-(tin) colloid uptake in renal transplants was quantified to evaluate rejection. A dynamic acquisition following i.v. injection of 110 MBq of this radiopharmaceutical enabled quantification of 15 to 20 min transplant uptake (PU), in terms of percentage of an injected dose after allowing for attenuation in the patient. An uptake ratio (UR) i.e. the ratio of 15 to 20 min uptake over the 0 to 5 min uptake was also derived. Normal values were obtained in 20 stable functioning transplants (normal PU less than or equal to 1%, normal UR less than or equal to 0.7). In 66 patients, PU and UR were compared with clinical, biochemical, histological and radiological, evidence of rejection. A sensitivity of 70% and specificity of 85% was obtained for this 99Tcm-(tin) colloid study in the diagnosis of renal transplant rejection.

Colloids↗

Sentinel lymph node biopsy in breast cancer using technetium-99m tin colloids of different sizes.

Axillary lymph node dissection (ALND) in the treatment of breast cancer is essential for predicting the prognosis and regional control of the tumor. At the same time ALND is associated with pain, numbness and sometimes lymphedema. Sentinel lymph node biopsy (SLNB) is a potential alternative procedure to conventional ALND in clinically node-negative breast cancer. In this study, we prepared the technetium-99m-labeled tin colloids with different sizes and compared their efficacy in SLNB. From September 1998 to February 2002, 184 clinically node-negative breast cancer patients were enrolled in the study at Keio University Hospital. Sentinel lymph nodes (SLNs) were identified by both blue dye and radioisotope. We prepared small-sized technetium-99m-labeled tin colloid (particle size: 200-400 nm in diameter). Regular-sized technetium-99m-labeled tin colloid is 400-1000 nm in diameter. In 74 patients, a SLNB was performed using regular-sized tin colloid; small-sized tin colloid was used in 110 patients. Subsequently, all of the patients were immediately followed by ALND. All dissected lymph nodes were evaluated by routine histopathological examination. The clinicopathological characteristics of the two groups were comparable. The lymphoscintigram detected SLN more frequently in the small-sized colloid group than in the regular-sized colloid group (P < 0.01). Small-sized tin colloid was also superior to regular-sized tin colloid in the SLN identification rate (97.3% versus 86.5%; P = 0.01). The mean value for ex vivo counts of the hottest sentinel lymph nodes of the small-sized colloid group was significantly higher than the counts of the regular-sized colloid group (P < 0.01). There was no significant difference in the accuracy between the two groups. It was concluded that SLNB using the small-sized tin colloid was technically feasible and provided higher detection and identification rates than the regular-sized tin colloid.

Adult↗

Formation of large particles in a 99Tcm-tin colloid preparation.

The effect of prolonged continuous movement on particle size within a 99Tcm-tin colloid preparation was investigated, making use of photon correlation spectroscopy for size estimation. No increase in particle size was found when the preparation was left undisturbed for up to 7 h, the mean (+/- S.D.) size being found to be 239 +/- 24 nm. When the preparation was placed in a laboratory rotator for the same period of time, there was a gradual increase in mean particle size to 404 +/- 127 nm. The increase in size was much greater, however, after 7 h of continuous agitation in a laboratory shaker, a mean value of 2260 +/- 746 nm being observed. An antimony sulphide colloid was subjected to continuous agitation for the same period of time but there was no evidence of aggregation. It is supposed that continuous movement of reconstituted 99Tcm-tin colloid, leading to a marked increase in particle size, may explain occasional instances of significant lung intake.

Humans↗

Dual radionuclide subtraction imaging of vertebral disc infection using an 111In-labelled leucocyte scan and a 99mTc-tin colloid scan.

Interpretation of the posterior view of an 111In-labelled leucocyte scan is difficult when infection is suspected in that region of the spine overlaid by the left lobe of the liver. A case is reported of the successful localisation of infection in this region by combining an 111In-labelled leucocyte scan with a 99mTc-tin colloid scan in a dual radionuclide subtraction technique.

Aged↗

Particle size and surface charge studies of a tin colloid radiopharmaceutical for liver scintigraphy.

The change in particle size of the liver scanning tin colloid radiopharmaceutical (Amerscan) has been determined using the non-perturbing method of photon correlation spectroscopy. Although samples of the tin colloid taken from the preparation vial immediately after preparation and allowed to remain undisturbed in the light scattering cell grow to sizes of ca. 1,200 nm radius, when samples are taken by syringe from the preparation vial at varying times, the particle size is only ca. 400 nm radius. This effect has been shown to be due to shear deflocculation within the syringe needle. Thus, as the tin colloid is always administered in the clinical situation with a syringe, the size of particle which the patient receives is satisfactory for liver uptake. The tin colloid has been shown to be essentially a charge-stabilised colloidal system from measurements of both zeta potential and effect of electrolyte on the flocculation process.

Electricity↗

pi-Indenyl tin(II) and lead(II) compounds.

The syntheses and structures of the first indenyl-substituted tin(II) complexes, [Sn{1,3-(SiMe3)2C9H5}2] and [Sn(C5Me5)-{1,3-(SiMe3)2C9H5}], are described; the lead(II) analogue of the latter compound has also been prepared and structurally characterized.

Journal Article↗

Liver hemangioma. A perioperative Tc-99m RBC SPECT correlation.

Scintigraphic diagnosis of a liver hemangioma may be difficult when its size approaches the spatial resolution of a gamma camera, and it may not be visualized on a Tc-99m tin-colloid liver SPECT study. The contribution of Tc-99m labeled RBC scintigraphy is shown in a patient with a liver hemangioma discovered during laparoscopic cholecystectomy for chronic cholecystitis. Despite negative CT, US, and Tc-99m tin-colloid SPECT of the liver, Tc-99m labeled RBC SPECT disclosed a focus of increased activity consistent with the hemangioma.

Colloids↗